FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361814254> ?p ?o ?g. }

• W4361814254 abstract "<div>Abstract<p>Structurally diverse histone deacetylase inhibitors (HDACI) have emerged as chemotherapeutic agents. Here, we report the first mercaptoacetamide HDACIs (coded 6MAQH and 5MABMA) for use in treatment against prostate cancer cells <i>in vitro</i> and <i>in vivo</i> and correlate their plasma pharmacokinetics and tissue-pharmacodynamics with tumor sensitivity. HDACIs were assessed for <i>in vitro</i> microsomal stability and growth inhibition against prostate cancer and nonmalignant cells. Antitumor activity was determined following i.p. administration of 6MAQH and 5MABMA (0.5 and 5 mg/Kg) using mice bearing PC3 tumor xenografts (<i>n</i> = 10). The plasma pharmacokinetics of 6MAQH and 5MABMA and their effects on the acetylation of histone H4 in tissues were determined in athymic mice. Both HDACIs significantly inhibited the growth of cancer cells while exerting limited effect on nonmalignant cells. They exhibited stability in human, dog, and rat microsomes [t_{<i>1/2</i> (min)} = 83, 72, and 66 for 6MAQH and 68, 43, and 70 for 5MABMA, respectively]. Both HDACIs (0.5 mg/Kg) led to tumor regression (<i>P</i> < 0.01), which was sustained for at least 60 days. <i>In vivo</i> data show favorable plasma pharmacokinetics with the area under the curve of 4.97 ± 0.6 μmol/L × h for 6MAQH and 4.23 ± 0.43 μmol/L × h for 5MABMA. The clearance rates for 6MAQH and 5MABMA were 4.05 ± 0.15 and 4.87 ± 0.2 L/h, whereas the half-lives were 2.2 ± 0.33 and 1.98 ± 0.21 h, respectively. Both HDACIs markedly enhanced the acetylation of histone H4 within 30 minutes in tissues, including the brain, liver, and spleen. Taken together, the results provide a rationale for further investigation of these mercaptoacetamide HDACIs as potent anticancer agents. [Mol Cancer Ther 2009;8(10):2844–51]</p></div>" @default.
• W4361814254 created "2023-04-05" @default.
• W4361814254 creator A5006488341 @default.
• W4361814254 creator A5031143138 @default.
• W4361814254 creator A5049863960 @default.
• W4361814254 creator A5062033506 @default.
• W4361814254 date "2023-03-31" @default.
• W4361814254 modified "2023-09-27" @default.
• W4361814254 title "Data from Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors" @default.
• W4361814254 doi "https://doi.org/10.1158/1535-7163.c.6532218" @default.
• W4361814254 hasPublicationYear "2023" @default.
• W4361814254 type Work @default.
• W4361814254 citedByCount "0" @default.
• W4361814254 crossrefType "posted-content" @default.
• W4361814254 hasAuthorship W4361814254A5006488341 @default.
• W4361814254 hasAuthorship W4361814254A5031143138 @default.
• W4361814254 hasAuthorship W4361814254A5049863960 @default.
• W4361814254 hasAuthorship W4361814254A5062033506 @default.
• W4361814254 hasBestOaLocation W43618142542 @default.
• W4361814254 hasConcept C104317684 @default.
• W4361814254 hasConcept C111113717 @default.
• W4361814254 hasConcept C112705442 @default.
• W4361814254 hasConcept C119157956 @default.
• W4361814254 hasConcept C150903083 @default.
• W4361814254 hasConcept C185592680 @default.
• W4361814254 hasConcept C202751555 @default.
• W4361814254 hasConcept C207001950 @default.
• W4361814254 hasConcept C2778305200 @default.
• W4361814254 hasConcept C502942594 @default.
• W4361814254 hasConcept C55493867 @default.
• W4361814254 hasConcept C64927066 @default.
• W4361814254 hasConcept C71924100 @default.
• W4361814254 hasConcept C86803240 @default.
• W4361814254 hasConcept C98274493 @default.
• W4361814254 hasConceptScore W4361814254C104317684 @default.
• W4361814254 hasConceptScore W4361814254C111113717 @default.
• W4361814254 hasConceptScore W4361814254C112705442 @default.
• W4361814254 hasConceptScore W4361814254C119157956 @default.
• W4361814254 hasConceptScore W4361814254C150903083 @default.
• W4361814254 hasConceptScore W4361814254C185592680 @default.
• W4361814254 hasConceptScore W4361814254C202751555 @default.
• W4361814254 hasConceptScore W4361814254C207001950 @default.
• W4361814254 hasConceptScore W4361814254C2778305200 @default.
• W4361814254 hasConceptScore W4361814254C502942594 @default.
• W4361814254 hasConceptScore W4361814254C55493867 @default.
• W4361814254 hasConceptScore W4361814254C64927066 @default.
• W4361814254 hasConceptScore W4361814254C71924100 @default.
• W4361814254 hasConceptScore W4361814254C86803240 @default.
• W4361814254 hasConceptScore W4361814254C98274493 @default.
• W4361814254 hasLocation W43618142541 @default.
• W4361814254 hasLocation W43618142542 @default.
• W4361814254 hasOpenAccess W4361814254 @default.
• W4361814254 hasPrimaryLocation W43618142541 @default.
• W4361814254 hasRelatedWork W1893200055 @default.
• W4361814254 hasRelatedWork W1998587742 @default.
• W4361814254 hasRelatedWork W2004556784 @default.
• W4361814254 hasRelatedWork W2115049423 @default.
• W4361814254 hasRelatedWork W2167792947 @default.
• W4361814254 hasRelatedWork W2227061539 @default.
• W4361814254 hasRelatedWork W2378945660 @default.
• W4361814254 hasRelatedWork W2582907174 @default.
• W4361814254 hasRelatedWork W2753834235 @default.
• W4361814254 hasRelatedWork W2992709639 @default.
• W4361814254 isParatext "false" @default.
• W4361814254 isRetracted "false" @default.
• W4361814254 workType "article" @default.